Jamie Irvine

Research sheds new light on cancer risk in gene therapies

Nick Armstrong, Senior Director of Digital Enablement at CAI, discusses the realities of digital enablement, artificial intelligence, and more.

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?

Exploring the potential of hybrid peptide-DNA nanostructures and artificial life

How multi-omics and AI-driven target identification can drive the future of personalized medicine

A superbug vaccine could protect patients against multiple healthcare-associated infections at once

The Medicine Maker’s all-inclusive advent calendar…

A deep dive into the dangers of fentanyl entering the US supply chain – and the importance of the Drug Supply Chain Security Act

Exploring the ins and outs of a recent UK-based collaboration between two prominent advanced medicine players

Experimental insomnia drug shows promise in alleviating opioid withdrawal symptoms and opioid-seeking behavior